FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Apr 24, 2012
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on April 24, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA, Inc.
- Inspection Date
- April 24, 2012
- Product Type
- Biologics
View Company Profile
ID · 7ed59914-3936-4e1e-8527-8102e82d79a6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 785185
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 630.40(a)Notification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 18, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 6, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 5, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 23, 2010 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1071044 - 2018-10-18
- FDA Inspection 988681 - 2016-10-06
- FDA Inspection 865425 - 2014-02-05
- FDA Inspection 669894 - 2010-06-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.